Zydus Lifesciences informs about press release

08 Apr 2026 Evaluate
Zydus Lifesciences has informed that it enclosed a copy of press release dated April 8, 2026, titled ‘Zydus receives final approval from USFDA for Dapagliflozin Tablets, 5 mg and 10 mg’.

The above information is a part of company’s filings submitted to BSE. 

Zydus Lifesciences Share Price

903.40 11.85 (1.33%)
09-Apr-2026 11:15 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1717.20
Dr. Reddys Lab 1207.00
Cipla 1226.90
Zydus Lifesciences 903.40
Lupin 2291.70
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×